Roche Launches Global BAP1 Test for Mesothelioma Diagnosis

Roche launched the VENTANA BAP1 (SP527) IHC assay for differential diagnosis of mesothelioma. The assay is registered as a Class I IVD with the FDA and IVDR Class C and is available globally.